{
 "source": "https://peptidefix.io/compound-labs",
 "note": "peptidefix.io is an informational reference. Nothing here is medical advice or a recommendation to use any substance. Compound Labs listings are not endorsements. Australian listings never include named peptides, because Australian law restricts advertising prescription-only medicines to the public.",
 "regions": {
  "US": {
   "name": "United States",
   "intro": "The United States is the only region with enough public detail to compare compounders. Most name a few peptides on their product pages, several carry public FDA records, and the hospital-supply facilities mostly make oxytocin.",
   "legal": [
    "A 503A pharmacy compounds against a prescription for a named patient and is regulated by its state pharmacy board. A 503B outsourcing facility registers with the FDA, follows current good manufacturing practice (cGMP) and can supply clinics with stock for use in the office. Several firms hold both. The wellness peptides on this page (sermorelin, GHK-Cu, gonadorelin) come from the 503A side of those firms.",
    "Whether a substance can be compounded at all depends on the FDA's bulk drug substances lists. Ipamorelin, GHRP-2, GHRP-6 and kisspeptin-10 remain on the FDA's Category 2 list of substances that may present significant safety risks. Nominations for BPC-157, TB-500, CJC-1295, GHK-Cu, thymosin alpha-1 and others were withdrawn, and the FDA page was last updated on 22 April 2026. A withdrawn nomination does not make a substance approved.",
    "On 23 and 24 July 2026 an FDA advisory committee voted to add six peptides, including BPC-157, to the 503A bulks list. Those votes are not binding until the FDA completes rulemaking. Compounding of GLP-1 drugs on shortage grounds ended in 2025, and the FDA now pursues compounded products that are \"essentially copies\" of approved drugs."
   ],
   "sources": [
    {
     "label": "FDA: Category 2 bulk drug substances",
     "url": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks"
    },
    {
     "label": "AJMC: FDA panel backs 6 peptides for compounding",
     "url": "https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compounding"
    },
    {
     "label": "FDA: policies for compounders as GLP-1 supply stabilizes",
     "url": "https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize"
    }
   ]
  },
  "UK": {
   "name": "United Kingdom",
   "intro": "Three UK businesses tie themselves to peptides: Nova (an aseptic peptide capability), PCCA (sublingual semaglutide) and Roseway Labs (oxytocin). Two more licensed sterile makers are listed because they hold MHRA specials licences, but they name no peptides.",
   "legal": [
    "UK compounding runs through two routes. One is an MHRA \"specials\" (MS) licence, which is GMP-inspected and lets the holder sell to other organisations. The other is the section 10 exemption for a registered pharmacy, overseen by the General Pharmaceutical Council (GPhC). Under both, the patient gets the product only through a prescriber.",
    "Licensed semaglutide and tirzepatide exist in the UK, so a compounded copy is hard to justify. In April 2026 the MHRA opened an investigation into clinics marketing \"experimental\" peptide injections and said it disregards \"research purposes\" disclaimers. The GPhC has reminded pharmacy owners that they carry due-diligence responsibility for their suppliers. Licences on this page were checked against the MHRA register of specials manufacturers (September 2026) and GPhC records."
   ],
   "sources": [
    {
     "label": "SPS: making unlicensed medicines",
     "url": "https://www.sps.nhs.uk/articles/making-unlicensed-medicines/"
    },
    {
     "label": "Pharmacy Business: MHRA peptide injections investigation",
     "url": "https://www.pharmacy.biz/mhra-peptide-injections-investigation-uk/"
    },
    {
     "label": "The Pharmacist: grey market peptides",
     "url": "https://www.thepharmacist.co.uk/clinical/nutrition-and-gastroenterology/grey-market-peptides-what-pharmacists-need-to-know/"
    },
    {
     "label": "MHRA register of specials manufacturers, September 2026",
     "url": "https://assets.publishing.service.gov.uk/media/6a9a9112df4246cf45e4693c/MS_Register_-_September_2026.csv"
    }
   ]
  },
  "AU": {
   "name": "Australia",
   "withhold": true,
   "intro": "Several Australian pharmacies say on their own pages or documents that they compound peptides, and several capable sterile compounders publish no peptides at all. Australian law forbids advertising prescription-only (Schedule 4) medicines to the public, so this page does not show which peptides an Australian pharmacy names. Each pharmacy's own website is linked.",
   "legal": [
    "Pharmacists may compound small quantities of medicines for an individual patient in response to a prescription, under an exemption in the Therapeutic Goods Regulations. The buyer is therefore always a patient with a prescription, not a clinic buying stock. A University of Sydney law lecturer has argued that bulk batches posted interstate amount to unlicensed manufacturing.",
    "Several peptides have been prescription-only (Schedule 4) substances since 2024; the peptide pages on this site give the status of each. Compounding GLP-1 drugs has been banned since 1 October 2024. In 2026 the Therapeutic Goods Administration (TGA) made unapproved peptides an enforcement priority, and its advertising ban covers websites and affiliates. Telehealth clinics that offer peptides in Australia generally do not name the pharmacy that dispenses them."
   ],
   "sources": [
    {
     "label": "Australian Pharmacist: the peptide surge has reached compounding",
     "url": "https://www.australianpharmacist.com.au/the-peptide-surge-has-reached-compounding/"
    },
    {
     "label": "TGA: final decisions on the Poisons Standard, 2024",
     "url": "https://www.tga.gov.au/sites/default/files/2024-05/notice-final-decisions-amend-not-amend-current-poisons-standard-november-2023.pdf"
    },
    {
     "label": "TGA: GLP-1 pharmacy compounding changes",
     "url": "https://www.tga.gov.au/news/media-releases/update-glucagon-peptide-1-receptor-agonists-glp-1-ras-pharmacy-compounding-changes"
    },
    {
     "label": "DLA Piper: TGA peptides crackdown",
     "url": "https://www.dlapiper.com/en/insights/publications/2026/06/peptides-crackdown-tga-updates-compliance-priorities-to-target-unapproved-peptide-products"
    },
    {
     "label": "The Conversation: how wellness clinics bend the rules",
     "url": "https://theconversation.com/how-wellness-clinics-bend-the-rules-to-supply-unapproved-peptides-and-anti-ageing-injections-287884"
    }
   ]
  },
  "EU": {
   "name": "Europe",
   "intro": "Searches in six languages found no licensed EU or Swiss pharmacy that publicly compounds BPC-157, TB-500, sermorelin, ipamorelin or similar peptides. One German pharmacy confirms a compounded peptide, an oxytocin nasal spray, and another makes glutathione infusions. The other pharmacies listed make sterile preparations for hospitals, pharmacies and clinics and name no peptides.",
   "legal": [
    "Pharmacy preparations fall outside EU marketing authorisation, so each country sets its own rules. A 2016 Council of Europe resolution asks for pharmacopoeia-grade ingredients and advises against compounding where an authorised equivalent exists. In Switzerland, pharmacies may compound peptides only on prescription and only from Swissmedic-approved starting materials. German mail-order pharmacies cannot ship batch-prepared compounds nationwide.",
    "The buyer is therefore a patient with a prescription, or another pharmacy or hospital, and the realistic peptide products are oxytocin-type preparations that have a licensed reference medicine. Rules differ by country and change; check the national regulator."
   ],
   "sources": [
    {
     "label": "EDQM: resolution on quality and safety standards in pharmaceutical practice",
     "url": "https://www.edqm.eu/en/resolutions-quality-and-safety-standards-in-pharmaceutical-practices-and-pharmaceutical-care"
    },
    {
     "label": "swissinfo: what is behind the peptide boom (August 2026)",
     "url": "https://www.swissinfo.ch/ger/innovationen-im-gesundheitswesen/was-hinter-dem-peptid-boom-steckt-und-was-das-f%C3%BCr-die-schweiz-bedeutet/91898776"
    },
    {
     "label": "apotheke adhoc: no Defektur privilege for mail-order pharmacies",
     "url": "https://www.apotheke-adhoc.de/nachrichten/detail/apothekenpraxis/apothekenrezepturen-kein-defektur-privileg-fuer-versandapotheken/"
    }
   ]
  }
 },
 "compound_labs": [
  {
   "id": "empower-pharmacy",
   "name": "Empower Pharmacy",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Houston",
   "admin": "Texas",
   "website": "https://www.empowerpharmacy.com",
   "address": "503A: 7601 N. Sam Houston Pkwy W., Ste 100, Houston, TX 77064. 503B: 5980 W. Sam Houston Pkwy N., Ste 300, Houston, TX 77041.",
   "phone": null,
   "email": null,
   "licence": "Operates a 503A pharmacy and a 503B outsourcing facility, and says it is registered with the FDA as a 503B and accredited by PCAB (company claims).",
   "sells_to": "503A: patients with a prescription. 503B: hospitals, medical offices and pharmacies.",
   "peptides": [
    "GHK-Cu (topical)",
    "Sermorelin",
    "Gonadorelin",
    "Semaglutide with B12",
    "Tirzepatide combinations"
   ],
   "peptide_note": "Named on its own peptides page.",
   "peptide_ids": [
    "ghk-cu",
    "sermorelin",
    "semaglutide",
    "tirzepatide"
   ],
   "sourcing": "\"USP quality ingredients from FDA-registered sources\", as stated.",
   "testing": "503B: in-house assay, pH, particulate, endotoxin and sterility testing. 503A: third-party testing and stability studies. As stated.",
   "records": [
    {
     "date": "2026-09-18",
     "text": "FDA warning letter to the 503A pharmacy, citing GLP-1 products the FDA calls \"essentially copies\" of approved drugs and insanitary conditions.",
     "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026"
    },
    {
     "date": "2025-04-02",
     "text": "FDA warning letter to the 503B facility.",
     "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharma-700962-04022025"
    },
    {
     "date": "2017-2021",
     "text": "Earlier FDA warning letters were issued in 2017, 2018 and 2021.",
     "url": null
    }
   ],
   "last_checked": "2026-10-01"
  },
  {
   "id": "olympia-pharmacy",
   "name": "Olympia Pharmacy",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Orlando",
   "admin": "Florida",
   "website": "https://www.olympiapharmacy.com",
   "address": "503B: 6700 Conroy Windermere Rd, Ste 155, Orlando, FL 32835. 503A: 4600 L B McLeod Rd, Orlando, FL 32811.",
   "phone": "(407) 673-2222",
   "email": null,
   "licence": "Operates a 503A pharmacy and a 503B outsourcing facility. Lists LegitScript and NABP.",
   "sells_to": "Patients (503A), practitioners and central-fill pharmacies.",
   "peptides": [],
   "peptide_note": "Its site refers to peptides without naming them. A clinic information sheet that cites it names sermorelin.",
   "peptide_ids": [
    "sermorelin"
   ],
   "sourcing": null,
   "testing": null,
   "records": [
    {
     "date": "2025-08-08",
     "text": "FDA published a Form 483 inspection record. Earlier Form 483s date from 2013 and 2018, and the FDA issued a warning letter in 2016.",
     "url": "https://www.fda.gov/about-fda/fda-commissioner/olympia-pharmaceuticals-orlando-fl-483-issued-08082025"
    }
   ],
   "last_checked": "2026-10-01"
  },
  {
   "id": "wells-pharmacy-network",
   "name": "Wells Pharmacy Network",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Ocala",
   "admin": "Florida",
   "website": "https://wellsrx.com/",
   "address": null,
   "phone": null,
   "email": null,
   "licence": "Operates 503A and 503B facilities. Says it is accredited by PCAB (company claim).",
   "sells_to": "503A: patients. 503B: physician office use.",
   "peptides": [
    "Sermorelin",
    "Glutathione"
   ],
   "peptide_note": "Named on its own product pages.",
   "peptide_ids": [
    "sermorelin",
    "glutathione"
   ],
   "sourcing": null,
   "testing": null,
   "records": [
    {
     "date": "2022-05-19",
     "text": "FDA untitled letter to its Dyersburg, Tennessee site.",
     "url": "https://www.fda.gov/media/163363/download"
    }
   ],
   "last_checked": "2026-10-01"
  },
  {
   "id": "belmar-pharma-solutions",
   "name": "Belmar Pharma Solutions",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Lakewood",
   "admin": "Colorado",
   "website": "https://www.belmarpharmasolutions.com/",
   "address": "503B facility: 12860 W. Cedar Dr, Ste 211, Lakewood, CO 80228.",
   "phone": "877-267-3410",
   "email": null,
   "licence": "Operates 503A and 503B facilities. Lists NABP and LegitScript.",
   "sells_to": "503B: prescriber offices (no peptides). 503A: patients.",
   "peptides": [
    "Sermorelin"
   ],
   "peptide_note": "Sermorelin is on its 503A product list.",
   "peptide_ids": [
    "sermorelin"
   ],
   "sourcing": "\"From FDA-registered drug facilities\", as stated.",
   "testing": "503B: independent third-party identity, strength and purity testing, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "hallandale-pharmacy",
   "name": "Hallandale Pharmacy",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Fort Lauderdale",
   "admin": "Florida",
   "website": "https://hallandalerx.com",
   "address": "2666 SW 36th St, Fort Lauderdale, FL 33312.",
   "phone": "(954) 455-3822",
   "email": "orders@hallandalerx.com",
   "licence": "503A pharmacy. Lists PCAB and LegitScript.",
   "sells_to": "Prescription only, through a provider login.",
   "peptides": [],
   "peptide_note": "Its site has a \"peptide therapy\" category but names no specific peptides.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "strive-pharmacy",
   "name": "Strive Pharmacy",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Gilbert",
   "admin": "Arizona",
   "website": "https://www.strivepharmacy.com",
   "address": null,
   "phone": null,
   "email": null,
   "licence": "503A pharmacy. Lists NABP, PCAB and LegitScript.",
   "sells_to": "Patients with a prescription.",
   "peptides": [],
   "peptide_note": "Says it stopped compounding peptides outside approved pathways and will bring them back in measured phases after the July 2026 FDA advisory committee vote (blog post, August 2026). It publishes no peptide list.",
   "peptide_ids": [],
   "sourcing": "\"Qualifying suppliers\", as stated.",
   "testing": "Analytical and stability testing through third-party labs, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "quva-pharma",
   "name": "QuVa Pharma",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": "Sugar Land",
   "admin": "Texas",
   "website": "https://onequva.com",
   "address": "3 Sugar Creek Center Blvd, Ste 250, Sugar Land, TX 77478.",
   "phone": "(888) 339-0874",
   "email": "Customer.Service@oneQuva.com",
   "licence": "FDA-registered 503B outsourcing facility.",
   "sells_to": "Hospitals only.",
   "peptides": [
    "Oxytocin"
   ],
   "peptide_note": "Named on its 503B product pages.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "sca-pharmaceuticals",
   "name": "SCA Pharmaceuticals",
   "region": "US",
   "country": "US",
   "country_name": "United States",
   "city": null,
   "admin": null,
   "website": "https://scapharma.com",
   "address": null,
   "phone": "(877) 550-5059",
   "email": null,
   "licence": "503B outsourcing facility working to cGMP.",
   "sells_to": "Hospitals.",
   "peptides": [
    "Oxytocin"
   ],
   "peptide_note": "Oxytocin bags are named in a post on a trade marketplace, not on SCA's own pages.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": "Sterility, endotoxin, potency and identity testing on every batch, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "nova-laboratories",
   "name": "Nova Laboratories",
   "region": "UK",
   "country": "GB",
   "country_name": "United Kingdom",
   "city": "Wigston, Leicester",
   "admin": "England",
   "website": "https://www.novalabs.co.uk/",
   "address": "Martin House, Gloucester Crescent, Wigston, Leicester LE18 4YL.",
   "phone": null,
   "email": null,
   "licence": "MHRA specials licence MS 13581 (aseptic small-volume liquids) and manufacturer's licence MIA(IMP) 13581.",
   "sells_to": "NHS hospitals and community pharmacies. Business to business only.",
   "peptides": [],
   "peptide_note": "Lists \"peptides\" as an aseptic capability for contract and clinical-trial work. No named products.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": "In-house quality control and microbiology, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "pcca-uk",
   "name": "PCCA Ltd (PCCA Pharmacy)",
   "region": "UK",
   "country": "GB",
   "country_name": "United Kingdom",
   "city": "Prudhoe",
   "admin": "England",
   "website": "https://pccarx.co.uk/",
   "address": "Units 2-3 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe NE42 6PX.",
   "phone": null,
   "email": null,
   "licence": "MHRA specials licence MS 17661 (non-sterile only) and wholesale dealer's licence WDA(H) 17661. Its on-site pharmacy is registered with the GPhC (9012165).",
   "sells_to": "Pharmacies, doctors, hospitals, clinics and wholesalers. Patients through its on-site pharmacy.",
   "peptides": [
    "Semaglutide (sublingual, not MHRA-approved)"
   ],
   "peptide_note": "Also markets a cosmetic peptide cream.",
   "peptide_ids": [
    "semaglutide"
   ],
   "sourcing": null,
   "testing": "A certificate of conformity or analysis with every product, as stated.",
   "records": [
    {
     "date": "2025-09-29",
     "text": "GPhC reinspection of PCCA Pharmacy: all standards met.",
     "url": "https://inspections.pharmacyregulation.org/pharmacy/detail/pcca-pharmacy-9012165"
    },
    {
     "date": "2025-02",
     "text": "GPhC inspection of PCCA Pharmacy: one standard (1.2) not met.",
     "url": "https://inspections.pharmacyregulation.org/pharmacy/detail/pcca-pharmacy-9012165"
    }
   ],
   "last_checked": "2026-10-01"
  },
  {
   "id": "roseway-labs",
   "name": "Roseway Labs",
   "region": "UK",
   "country": "GB",
   "country_name": "United Kingdom",
   "city": "Basildon",
   "admin": "England",
   "website": "https://rosewaylabs.com/",
   "address": "Unit 14, Repton Close, Basildon SS13 1LJ.",
   "phone": "03330 504030",
   "email": "info@rosewaylabs.com",
   "licence": "Registered pharmacy with the GPhC (9012117 and 9013149), operating under the section 10 exemption. No MHRA specials licence.",
   "sells_to": "Private prescriptions. Says it supplies over 1,000 medical clinics.",
   "peptides": [
    "Oxytocin"
   ],
   "peptide_note": "Dosage form not stated on its page.",
   "peptide_ids": [],
   "sourcing": "\"Pharmaceutical-grade ingredients\", as stated.",
   "testing": null,
   "records": [
    {
     "date": "2024-10-23",
     "text": "GPhC inspection of Roseway Labs: all standards met.",
     "url": "https://inspections.pharmacyregulation.org/pharmacy/detail/roseway-labs-9012117"
    }
   ],
   "last_checked": "2026-10-01"
  },
  {
   "id": "quantum-pharmaceutical",
   "name": "Quantum Pharmaceutical",
   "region": "UK",
   "country": "GB",
   "country_name": "United Kingdom",
   "city": "Burnopfield",
   "admin": "England",
   "website": "https://www.quantumpharmaceutical.co.uk/",
   "address": "Quantum House, Hobson Industrial Estate, Burnopfield NE16 6EA.",
   "phone": "0800 0439 372",
   "email": "orders@quantumpharma.co.uk",
   "licence": "MHRA specials licence MS 21923 (aseptic) and wholesale dealer's licence WDA(H) 21923.",
   "sells_to": "Not published.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "States it runs more than 250 quality checks.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "ith-pharma",
   "name": "ITH Pharma",
   "region": "UK",
   "country": "GB",
   "country_name": "United Kingdom",
   "city": "London",
   "admin": "England",
   "website": "https://ithpharma.com/",
   "address": "Units 2 and 4, Premier Park, London NW10 7NZ (MHRA register).",
   "phone": null,
   "email": null,
   "licence": "MHRA specials licence MS 33634 (aseptic).",
   "sells_to": "Registered trade accounts.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "byron-compounding-chemist",
   "name": "Byron Compounding Chemist",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "Surfers Paradise",
   "admin": "Queensland",
   "website": "https://byroncompounding.com.au/",
   "address": "Shop 13 Capri on Via Roma, 15 Via Roma, Isle of Capri, Surfers Paradise QLD 4217.",
   "phone": "+61 7 5526 7052",
   "email": "pharmacist@byroncompounding.com.au",
   "licence": "Community pharmacy. States it is \"compliant with Australian Pharmacy & TGA requirements\". No licence numbers published.",
   "sells_to": "Patients with a prescription, private-label work for clinics, and skincare sold to the public.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": "\"TGA-approved ingredients\" from approved wholesalers, as stated.",
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "the-compounding-lab",
   "name": "The Compounding Lab (Formulae Albion)",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "Albion",
   "admin": "Queensland",
   "website": "https://compoundinglab.com.au/",
   "address": "1/45 Crosby Rd, Albion QLD 4010.",
   "phone": "07 3862 6000",
   "email": "enquiries@compoundinglab.com.au",
   "licence": "Compounds under the pharmacist exemption. ABN 13 429 161 055, registered as a sole trader.",
   "sells_to": "Patients with a prescription.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "complementary-compounding-ballina",
   "name": "Complementary Compounding (Custom Medicine)",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "Ballina",
   "admin": "New South Wales",
   "website": "https://custommedicine.com.au/",
   "address": "1/130 Tamar St, Ballina NSW 2478.",
   "phone": "+61 2 6686 2244",
   "email": null,
   "licence": "Operates as Custom Medicine Pty Ltd, ABN 54 125 577 111.",
   "sells_to": "Patients with a doctor's prescription.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "Says it has a NATA-certified ISO 7 cleanroom with in-house sterility and endotoxin testing.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "central-labs-compounding-pharmacy",
   "name": "Central Labs Compounding Pharmacy",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "West Leederville",
   "admin": "Western Australia",
   "website": "https://centrallabs.com.au/",
   "address": "29 Oxford Close, West Leederville WA 6007.",
   "phone": "08 9221 1020",
   "email": "compounding@centrallabs.com.au",
   "licence": "ABN 73 673 943 206.",
   "sells_to": "Patients, prescribers, vets and clinical trials.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "Describes \"Quality Assured QC & QM\" without detail.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "oxford-compounding",
   "name": "Oxford Compounding",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "North Perth",
   "admin": "Western Australia",
   "website": "https://www.oxfordcompounding.com.au/",
   "address": "73 Angove St, North Perth WA 6006.",
   "phone": "08 9225 9400",
   "email": "info@oxfordcompounding.com.au",
   "licence": "PCCA member. Says its cleanrooms operate \"under TGA standards\".",
   "sells_to": "Individual prescriptions, hospitals, specialists and clinical trials.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "Stability and potency testing for clinical trials, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "mckenzies-compounding-chemist",
   "name": "McKenzies Compounding Chemist",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "Mount Lawley",
   "admin": "Western Australia",
   "website": "https://www.mckenzieschemist.com.au/compounding-pharmacy-perth/sterile-compounding/compounding-injections/",
   "address": "Unit 7, 689 Beaufort St, Mount Lawley WA 6050.",
   "phone": "(08) 9272 8726",
   "email": null,
   "licence": "PCCA member. Has an ISO 7 cleanroom.",
   "sells_to": "Prescription.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "Sterility, particulate and potency checks, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "asepticare",
   "name": "Asepticare",
   "region": "AU",
   "country": "AU",
   "country_name": "Australia",
   "city": "Shenton Park",
   "admin": "Western Australia",
   "website": "https://www.asepticare.com.au/",
   "address": "13A Bedbrook Place, Shenton Park WA 6008.",
   "phone": "(08) 6285 0356",
   "email": "info@asepticare.com.au",
   "licence": "ISO cleanrooms, described by the pharmacy as \"independently verified\".",
   "sells_to": "Patients, GPs, specialists, integrative practitioners and vets.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "Particle and microbial monitoring, as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "apomex",
   "name": "apomex",
   "region": "EU",
   "country": "DE",
   "country_name": "Germany",
   "city": null,
   "admin": null,
   "website": "https://www.apomex.net/",
   "address": null,
   "phone": null,
   "email": null,
   "licence": "German pharmacy compounding to individual prescription.",
   "sells_to": "Patients. Ships after the original prescription arrives.",
   "peptides": [
    "Oxytocin (nasal spray, made in-house)"
   ],
   "peptide_note": "Named on its own product page.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "viktoria-apotheke-saarbruecken",
   "name": "Viktoria Apotheke Dr. Trennheuser",
   "region": "EU",
   "country": "DE",
   "country_name": "Germany",
   "city": "Saarbrücken",
   "admin": "Saarland",
   "website": "https://viktoriaapothekesaarbruecken.de/",
   "address": "Bahnhofstraße 95/97, 66111 Saarbrücken.",
   "phone": "0681 910 055 00",
   "email": "info@internet-apotheke.de",
   "licence": "Commercial register HRA 13791. Supervised by the Apothekerkammer des Saarlandes.",
   "sells_to": "Doctors, Heilpraktiker, clinics and patients.",
   "peptides": [
    "S-acetyl-glutathione (infusions)"
   ],
   "peptide_note": "Glutathione is a tripeptide. It also makes NAD+ infusions, which are not a peptide.",
   "peptide_ids": [
    "glutathione"
   ],
   "sourcing": "Made in Germany. The active-ingredient supplier is not published.",
   "testing": "For one named product line, each batch's active ingredient is checked by an external lab (PharmBioTec GmbH), as stated.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "magistrel-glostrup-apotek",
   "name": "Magistrel (Glostrup Apotek)",
   "region": "EU",
   "country": "DK",
   "country_name": "Denmark",
   "city": "Glostrup",
   "admin": null,
   "website": "https://www.magistrel.dk/",
   "address": "Paul Bergsøes Vej 16, 2600 Glostrup.",
   "phone": "43 96 00 10",
   "email": "glostrup@magistrel.dk",
   "licence": "Pharmacy production unit. CVR 37302872.",
   "sells_to": "Doctors, pharmacies, hospitals and patients.",
   "peptides": [],
   "peptide_note": "Its catalogue is behind a login.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "fagron-sterile-services",
   "name": "Fagron Sterile Services",
   "region": "EU",
   "country": "BE",
   "country_name": "Belgium",
   "city": null,
   "admin": null,
   "website": "https://fagroncompoundingservices.be/en/fagron-sterile-services/",
   "address": null,
   "phone": null,
   "email": null,
   "licence": "Holds a compounding licence and works to GMP. Also operates in the Netherlands and the Czech Republic.",
   "sells_to": "Hospital pharmacies (business to business).",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": "Fagron is also a raw-material supplier.",
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "magis-pharma",
   "name": "Magis Pharma",
   "region": "EU",
   "country": "BE",
   "country_name": "Belgium",
   "city": "Wilrijk",
   "admin": null,
   "website": "https://www.magis-pharma.be/",
   "address": "Neerlandweg 24, 2610 Wilrijk.",
   "phone": "+32 3 457 11 76",
   "email": "info@magis-pharma.be",
   "licence": "Licence type not published.",
   "sells_to": "Practitioners and pharmacies. Offers outsourced preparation.",
   "peptides": [],
   "peptide_note": "Gives formula advice for an oxytocin nasal spray on its site but does not say it supplies one.",
   "peptide_ids": [],
   "sourcing": "Recommends a licensed Syntocinon ampoule as the starting material because bulk raw material is hard to obtain.",
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "farmacia-santamaria",
   "name": "Farmacia Santamaría",
   "region": "EU",
   "country": "ES",
   "country_name": "Spain",
   "city": "Granada",
   "admin": "Andalusia",
   "website": "https://farmaciasantamaria.com/",
   "address": "C/ Periodista José María Carrulla 8, 18014 Granada.",
   "phone": "+34 958 15 49 49",
   "email": "laboratorio@santamariapose.com",
   "licence": "Andalusian authorisation for all three compounding levels, including sterile and lyophilised preparations. AENOR certified.",
   "sells_to": "Other pharmacies, aesthetic, dermatology and veterinary clinics, and patients.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": "\"Strict quality controls\", no detail.",
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "farmacia-marro",
   "name": "Farmacia Marro",
   "region": "EU",
   "country": "ES",
   "country_name": "Spain",
   "city": "Huesca",
   "admin": "Aragon",
   "website": "https://www.farmaciamarro.com/",
   "address": "C/ Coso Bajo 54, 22001 Huesca.",
   "phone": "974 239 037",
   "email": "contacto@marrosalud.com",
   "licence": "AENOR certificate 14488.",
   "sells_to": "Patients, other pharmacies and hospital pharmacy services.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "farmacia-laboratorio-perello",
   "name": "Farmacia Laboratorio Perelló",
   "region": "EU",
   "country": "ES",
   "country_name": "Spain",
   "city": "Madrid",
   "admin": "Madrid",
   "website": "https://www.farmacialaboratorioperello.es/",
   "address": null,
   "phone": "601 903 733",
   "email": "info@farmacialaboratorioperello.es",
   "licence": "Describes a \"level 4\" compounding laboratory with cleanrooms.",
   "sells_to": "Professionals, pharmacies and patients.",
   "peptides": [],
   "peptide_note": null,
   "peptide_ids": [],
   "sourcing": null,
   "testing": null,
   "records": [],
   "last_checked": "2026-10-01"
  },
  {
   "id": "hohenzollern-apotheke",
   "name": "Hohenzollern Apotheke",
   "region": "EU",
   "country": "DE",
   "country_name": "Germany",
   "city": "Münster",
   "admin": "North Rhine-Westphalia",
   "website": "https://www.hohenzollern-apotheke.de/",
   "address": "Hohenzollernring 59, 48145 Münster.",
   "phone": "0251 2007800",
   "email": "ring@hza.de",
   "licence": "Certified by the German pharmacists' central laboratory (ZL).",
   "sells_to": "Patients, medical practices and homecare.",
   "peptides": [],
   "peptide_note": "Its compounding focus is paediatrics, dermatology and oncology.",
   "peptide_ids": [],
   "sourcing": null,
   "testing": "ZL certification.",
   "records": [],
   "last_checked": "2026-10-01"
  }
 ]
}